Brief: Kintara Therapeutics Received Notice From Nasdaq On Sept 20 On Not Being In Compliance With Minimum Stockholders' Equity Requirement
Sept 26 (Reuters) - Kintara Therapeutics Inc KTRA.O :
* KINTARA THERAPEUTICS - ON SEPT 20, RECEIVED NOTICE FROM
NASDAQ
ADVISING CO THAT IT IS NOT IN COMPLIANCE WITH MINIMUM
STOCKHOLDERS' EQUITY REQUIREMENT
* KINTARA THERAPEUTICS INC - COMPANY IS CURRENTLY EVALUATING
VARIOUS COURSES OF ACTION TO REGAIN COMPLIANCE
* KINTARA THERAPEUTICS INC - PLANS TO TIMELY SUBMIT ITS PLAN
TO
NASDAQ TO REGAIN COMPLIANCE WITH STOCKHOLDERS' EQUITY
REQUIREMENT
Further company coverage: KTRA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on TuHURA Biosciences
See all newsBrief: Tuhura Biosciences Receives Key U.S. Patent For Its Groundbreaking Delta Opioid Receptor Antibody Drug Conjugate Technology
TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.